• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·BALAMINES.NS
Share

Balaji Amines Limited Stocks

₹ 1751.8Last Updated 01.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₹ 605.80M

₹ 1751.8
Key Takeaways

Risk factor

Limited trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and CFL Lamps. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, and choline chloride; and pharma excipients, such as poly vinyl pyrrolidone. It serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, and water treatment chemical industries. In addition, the company operates Balaji Sarovar, a hotel in Solapur, Maharashtra; and manufactures and sells CFL lamps. It also exports its products to the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and internationally. The company was incorporated in 1988 and is based in Hyderabad, India.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of BALAMINES.NS is 1298 and suggests 26% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendatio

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

04.06.2026 08:00

Broadcom let down by software revenue and AI chip outlook. Shares tumble after record high

04.06.2026 07:00

Morgan Stanley called the debut of a new Fed chief a major risk to currency markets

04.06.2026 01:56

Elon Musk's SpaceX has announced its IPO share price. It wants to raise a record $75 billion

04.06.2026 01:50

Strait of Hormuz to open in June, JPMorgan says: oil stocks running out

04.06.2026 01:18

S&P falls for the first time after nine sessions of growth: investors are worried about inflation risks

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026